What we know is nothing's changed from the time we were at 9 except for pancreatic data, so what the hell's going on. Apparently shorters aren't to blame, no conspiracy by BP, yet the promise of a effective and non-toxic treatment for cancers doesn't seem to resonate with investors. Go figure how this could be when MRKR appears to be on the verge of game-changing cancer treatments!
News 
Market Data 
Discover 
